The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.
STUDY ASSUMPTION YEARS
CLINICAL NUTRITION MARKET KEY TAKEAWAYS
MARKET GROWTH FACTORS
1. Adoption of Clinical Nutrition Among the Geriatric Population
The growing number of older adults around the world is a major factor driving the clinical nutrition market, mainly because of the physiological changes that come with aging. As people get older, they often struggle with nutrient absorption and a slower metabolism, which can result in deficiencies, frailty, and chronic illnesses. This increased vulnerability has led to a greater need for specialized nutritional support. The market is expanding thanks to the vital role that nutritional supplements and medicinal foods play in tackling these challenges. For instance, products enriched with proteins, vitamins like B12 and D, and minerals such as calcium are crucial for addressing muscle loss and bone density concerns. This has paved the way for personalized therapies, where clinical nutrition experts design tailored dietary plans to manage specific health issues like diabetes, heart disease, or cognitive decline. This emphasis on customized, preventive, and disease-management-focused nutrition is transforming the clinical nutrition market by changing how healthcare is provided to the elderly, moving from reactive treatment to proactive wellness.
2. Rising Incidence of Chronic Diseases Driving Demand
The global clinical nutrition market is booming, and it’s largely because of the rising incidence of chronic diseases like diabetes, cancer, osteoporosis, and heart conditions. As these health issues become more common, there’s a heightened awareness of how essential nutritional therapy is for long-term management. Clinical nutrition provides specialized dietary interventions and products that help patients manage their symptoms, improve their quality of life, and lower the risk of complications. Moreover, a significant factor driving this growth is the preventive aspect of clinical nutrition, particularly for the elderly. With the global aging population increasing, so does the risk of malnutrition and health problems associated with aging. Customized nutrition plans and supplements are key in preventing disease and managing existing conditions, ensuring a better quality of life for older adults and driving market demand.
3. Increasing Demand for Fortified and Nutrient-Rich Foods
The rising global focus on health and wellness, coupled with the increasing prevalence of chronic diseases and malnutrition, is a significant driver for the clinical nutrition market. This demand is particularly strong for fortified and nutrient-rich foods that go beyond basic sustenance. Consumers are actively seeking products enriched with specific vitamins, minerals, and proteins to address dietary deficiencies and support overall well-being. This trend is leading to the development of a wide range of clinical nutrition products, including specialized formulas for infants, the elderly, and patients with specific medical conditions. Manufacturers are innovating to create functional foods that not only provide essential nutrients but also offer targeted health benefits like improved immunity, cognitive function, and digestive health. As health consciousness grows and people look for proactive ways to manage their health, the demand for these fortified products will continue to propel the clinical nutrition market forward.
Request for a sample copy of this report:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
Breakup by Route of Administration:
Breakup by Application:
Breakup by End User:
Breakup by Region:
REGIONAL INSIGHTS
Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.
RECENT DEVELOPMENTS & NEWS
Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.
KEY PLAYERS
Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Mainframe Market: https://www.imarcgroup.com/mainframe-market
Transthyretin Amyloidosis Treatment Market: https://www.imarcgroup.com/transthyretin-amyloidosis-treatment-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)